Target intelligence / Profile preview

Snake venom C-type lectin-like protein (Snaclec)

Target
Snaclec
Molecular classification
Venom protein, C-type lectin domain family, Toxin
01

Overview

Snake venom C-type lectin-like proteins (snaclecs) are a major family of non-enzymatic toxins found primarily in the venom of vipers and pit vipers (Clemetson, 2010, Toxicon). Structurally, they belong to the C-type lectin domain superfamily but generally lack the functional calcium-binding residues necessary for carbohydrate recognition, instead evolving to bind protein targets with high specificity (Morita, 2005, Toxicon). These proteins disrupt host hemostasis by binding to platelet receptors such as Glycoprotein Ib (GPIb), Glycoprotein VI (GPVI), and C-type lectin-like receptor 2 (CLEC-2), or to blood coagulation factors like Factor IX and Factor X (Lu et al., 2005, J Thromb Haemost). Such interactions can either induce or inhibit platelet aggregation and the coagulation cascade, leading to clinical complications like venom-induced consumptive coagulopathy and systemic hemorrhage (Eble, 2019, Molecules). In a therapeutic context, snaclecs are the primary targets for neutralization by antivenoms, which consist of antibodies that bind the toxins and prevent their interaction with host proteins. Furthermore, due to their high affinity for vascular receptors, snaclecs serve as valuable research tools and structural templates for the development of novel anticoagulant and antiplatelet drugs (Clemetson, 2010, Toxicon).

Other names
C-type lectin-like proteinsSV-CTLPsSnake venom lectin-related proteinsSnaclecs
02

Mechanism of action

Antivenom antibodies bind to the snaclec proteins, preventing their interaction with host platelet receptors and coagulation factors, thereby neutralizing their toxic effects on the hemostatic system.

03

Biological functions

Platelet aggregationBlood coagulationCell-cell adhesionHemostasis
04

Disease associations

Snakebite envenomationVenom-induced consumptive coagulopathyHemorrhageThrombosis
05

Safety considerations

AnaphylaxisSerum sicknessSystemic hemorrhageVenom-induced consumptive coagulopathy
06

Interacting drugs

Antivenom

3 more in the full profile.

07

Biomarkers

Platelet countProthrombin timeFibrinogen levelD-dimer

Beyond the preview

Go deeper on Snake venom C-type lectin-like protein (Snaclec).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Snake venom C-type lectin-like protein (Snaclec).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call